The first stage involved distribution training for the new distributor in South Korea, along with relationship building with our current partners in Japan and Thailand. The second stage took us on to Taiwan, which provided us with a unique opportunity to forge new relationships both in the way of distribution partners and also strategic partners, which align with the companies strategy moving forward.
“Taiwan is the 21st largest economy in the world, and the No.1 for entrepreneurship. As a result some of the companies coming out of Taiwan in our field are at the cutting edge of innovation, and we have begun building partnerships with these companies, which we feel represent both short-term and long term opportunities for Surgical Innovations.
SE Asia continues to be a significant part of Surgical Innovation’s focus, specifically Japan, where our partner is now our 2nd largest distributor for our flagship Yelloport+ product line. 2nd only to the UK.
With Yelloport Elite being launched shortly we have highlighted Japan as a key strategic partner for this product launch, and we believe this has the potential to offer continued growth in this market.” – Chris Rawnsley, Global Sales Manager.